Mechanism of protective action of bicyclol against CC14-induced liver injury in mice

Liver International

Volumn 25, Issue 4, 2005, Pages 872-879

  Liu, Geng Tao ^a,b   Li, Yan ^a   Wei, Huai Ling ^a   Zhang, Hui ^a   Xu, Ji Yan ^a   Yu, Ling Hong ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b NONE   (China)

Author keywords

Bicyclol; CCl4; Free radical; Hepatoprotection; Liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICYCLOL; CARBON TETRACHLORIDE; FREE RADICAL; LIPID; LIVER PROTECTIVE AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; COVALENT BOND; DRUG MECHANISM; ENZYME INHIBITION; ENZYME METABOLISM; EXPERIMENTAL ANIMAL; IN VITRO STUDY; LIPID PEROXIDATION; LIVER CELL DAMAGE; LIVER INJURY; LIVER MICROSOME; LIVER PROTECTION; LIVER STRUCTURE; MALE; MOUSE; NONHUMAN; PROTEIN CONTENT; RAT;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; BIPHENYL COMPOUNDS; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; HEPATITIS, ANIMAL; HEPATITIS, TOXIC; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; MICE; MICE, INBRED STRAINS; MICROSOMES, LIVER; PROTECTIVE AGENTS; PROTEINS; RATS; RATS, WISTAR;

EID: 22844437516     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01103.x     Document Type: Article

References (23)

1. Liu G T. Proposal for the strategy of prevention and treatment of chronic viral hepatitis and for research in China. Natl Med J China 2002; 82: 74-6.
2. Lok A S. Hepatitis B infection: pathogenesis and management. J Hepatol 2000; 32: 89-97.
3. Boyer N, Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol 2000; 32: 98-112.
4. Liaw Y F, Chien R N, Yeh C T, Tsai S L, Chu C C. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999; 30: 567-72.
5. Miyake K, Tango T, Ota Y, et al. Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis. J Gastroenterol Hepatol 2002; 17: 1198-204.
6. Liu G T. Therapeutic effects of biphenyl dimethyl dicarboxylate (DDB) on chronic viral hepatitis B. Proc CAMS and PUMC 1987; 2: 228-33.
7. Liu G T. The antivirus and hepatoprotective effect of bicyclol and its mechanism of action. Chin J New Drugs 2001; 10: 325-7.
8. Buege J A, Aust S D. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-10.
9. Segle H L, Beattic D S, Hoppe R S. Purification and properties of liver glutamic alanine transferase from normal and corticoid-treated rats. J Biol Chem 1962; 237: 1914-20.
10. Huang S H, Li S E, Zan B F, Yu Y. Studies on the mechanism of carcinogenesis. Vl. The immunochemistry of carbonyl phosphate synthetase in rat liver and hepatoma induced by diethylnitrosamine. Acta Biochem et Biophys Sin 1982; 14: 407-15.
11. Omura T, Sato R. The carbon monoxide pigment of liver microsomes. 1. Evidence for its haemoprotein nature. J Biol Chem 1964; 239: 2370-6.
12. Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
13. Gergel D, Misik V, Riesz P, Cederbaum A. Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide. Arch Biochem Biophys 1997; 337: 239-50.
14. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 1953; 55: 416-21.
15. Lubert R A, Mayer R T, Cameron J W. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys 1985; 238: 43-8.
16. 4: role of endogenous iron. In: Poli G, Cheeseman KH, Dianzani MU, Slater TF, eds. Free Radicals in Liver Injury. Oxford: IRL Press, 1987 pp. 87-90.
17. Zhao D M, Liu G T. The protective effect of bicyclol on concanavalin A-induced liver nuclear DNA injury in mice. Natl Med J China 2001; 81: 844-50.
18. Rust C, Gores G J. Apoptosis and liver disease. Am J Med 2000; 108: 567-74.
19. Nelson S D. Mechanism of the formation and disposition of reactive metabolites that can cause acute liver injury. Drug Metab Rev 1995; 27: 147-77.
20. Cohen S D, Khairallah E A. Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev 1997; 29: 59-77.
21. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol 2000; 32(Suppl. 1): 39-47.
22. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003; 34: 1-10.
23. Yao G B, Ji Y Y, Wang Q H, et al. A randomized double-blind controlled trial of bicyclol in treatment of chronic hepatitis B. Chin J New Drugs Clin Rem 2002; 21: 457-61.